# DESCRIPTION

## TECHNICAL FIELD

- relate to treating ischemic conditions

## BACKGROUND OF THE INVENTION

- introduce ischemic heart disease
- describe current treatment options
- limitations of current treatments
- introduce traditional Chinese medicine
- motivate need for new treatment options

## SUMMARY OF THE INVENTION

- introduce method of treating ischemic conditions
- describe carbohydrate composition
- extraction of carbohydrate composition
- isolate carbohydrate composition
- describe crude Panax ginseng extract
- fractionate crude extract
- add water and aliphatic alcohol
- subject to anion-exchange chromatography
- concentrate eluate
- describe method of protecting cells
- contact cells with carbohydrate composition
- describe pharmaceutical formulation
- describe use of carbohydrate composition
- describe benefits of carbohydrate composition
- summarize invention

## DETAILED DESCRIPTION OF THE INVENTION

- define technical terms
- explain meaning of "comprising"
- explain meaning of "essentially consisting of"
- explain meaning of "consisting of"
- introduce method of treating ischemic condition
- introduce method of preventing ischemia-reperfusion injury
- define "ischemic condition"
- specify ischemic condition affecting the heart
- define "ischemia-reperfusion injury"
- describe cellular damage after reperfusion
- introduce carbohydrate composition extracted from Panax ginseng
- specify subject as animal or human
- define "carbohydrate composition"
- describe carbohydrate portion
- define "carbohydrates"
- describe polysaccharides
- specify monosaccharides
- describe acidic polysaccharides
- specify preferred carbohydrate composition
- describe molecular weight of polysaccharide
- specify preferred monosaccharides
- describe carbohydrate portion content
- specify uronic acid content
- describe method of determining uronic acid content
- describe protein portion
- specify protein portion content
- describe method of determining protein content
- specify preferred carbohydrate portion composition
- describe extraction of carbohydrate composition from Panax ginseng
- specify administration of carbohydrate composition
- describe effective amount of carbohydrate composition
- specify pharmaceutical formulation
- describe excipients
- specify method of manufacturing pharmaceutical formulation
- describe preferred pharmaceutical formulation
- specify extraction steps
- describe drying and cutting of Panax ginseng plant material
- specify extraction solvent
- describe isolation of crude Panax ginseng extract
- define carbohydrate composition
- motivate extraction from Panax ginseng
- describe step (i) of providing crude Panax ginseng extract
- detail step a) of contacting Panax ginseng plant material with extraction solvent
- detail step b) of subjecting mixture to stirring, shaking, heating, sonication, or standing
- detail step c) of isolating crude Panax ginseng extract
- describe step (ii) of isolating carbohydrate composition from crude Panax ginseng extract
- detail step a) of fractionating crude Panax ginseng extract
- detail step b) of adding water and aliphatic alcohol to crude Panax ginseng extract
- detail step c) of subjecting carbohydrate-enriched precipitate to anion-exchange chromatography
- detail step d) of concentrating eluate
- describe alternative embodiments of step (ii)
- describe most preferred embodiments of step (ii)
- describe method of protecting cells against hypoxia and reoxygenation induced cell death
- detail contacting cells with carbohydrate composition
- describe concentration of carbohydrate composition used
- describe time of contacting cells with carbohydrate composition
- describe cells used, preferably cardiomyocytes
- define protecting cells against hypoxia and reoxygenation induced cell death
- describe effects of contacting cells with carbohydrate composition
- describe method for preparing carbohydrate composition
- describe carbohydrate composition extracted from Panax ginseng
- detail carbohydrate portion of carbohydrate composition
- describe molecular weight of carbohydrate composition
- describe further preferred embodiments of carbohydrate composition
- describe most preferred embodiments of carbohydrate composition
- describe method for preparing pharmaceutical formulation
- describe pharmaceutical formulation
- describe route of administration
- describe use of carbohydrate composition as medicament
- describe use of carbohydrate composition for preparing medicament
- describe use of carbohydrate composition for protecting cells against hypoxia and reoxygenation induced cell death
- detail step a) of fractionating crude Panax ginseng extract
- detail high-speed counter-current chromatography
- detail anion-exchange chromatography
- detail concentrating eluate
- describe crude Panax ginseng extract obtained in step (i)
- describe amounts of ginsenosides in crude Panax ginseng extract
- describe pharmaceutical formulation
- describe excipients used in pharmaceutical formulation
- describe form of pharmaceutical formulation
- describe route of administration

## EXAMPLES

- list reagents and materials
- describe preparation methods

### Example 1

- extract Panax ginseng
- prepare standardized ginseng extract
- establish chemical fingerprints
- identify and quantify ginsenosides
- fractionate crude extract using HSCCC
- isolate carbohydrate composition
- perform stepwise ethanol precipitation
- subject precipitates to anion-exchange chromatography
- elute and collect fractions
- isolate carbohydrate composition without HSCCC
- purify and obtain final carbohydrate composition

### Example 2

- introduce chemical characterization
- describe HPGPC analysis
- detail monosaccharide composition analysis
- outline chemical analysis
- introduce pharmacological characterization
- describe cell culture conditions
- outline statistical analysis
- detail cytotoxicity test
- describe hypoxia/reoxygenation conditions
- outline drug treatment
- detail pharmaceutical blockages
- describe assay for cell viability
- outline Western blot analysis
- detail measurement of nitric oxide production
- describe flow cytometric analysis of cardiomyocyte apoptosis
- summarize experimental design
- conclude pharmacological characterization
- introduce Annexin-V/PI kit
- describe cell culture and flow cytometry
- determine Caspase-3/7 and -9 activities
- measure mitochondrial membrane potential
- measure ATP content
- assess effect of AP1 on mitochondrial respiration
- describe results of fractionating Panax ginseng extract
- characterize RSE 2 and RSE 3 fractions
- describe further purification of RSE 2/RSE 3 mixture
- characterize carbohydrate composition AP1
- determine total sugar content of AP1
- determine uronic acid content of AP1
- determine protein content of AP1
- estimate apparent molecular weight of AP1
- analyze sugar composition of AP1
- evaluate effect of AP1 on H9c2 cell growth
- evaluate protective effect of AP1 against H/R-induced injury
- evaluate morphological change of H9c2 cells
- evaluate MVS assay results
- examine cardio-protective effect of AP1
- evaluate effect of AP1 on RISK pathway
- evaluate effect of AP1 on GR, ER, PI3K/Akt, and eNOS
- evaluate effect of AP1 on iNOS expression
- evaluate role of signaling pathways in cardio-protective effect of AP1
- evaluate effect of AP1 on NO production
- evaluate effect of AP1 on apoptosis
- evaluate effect of AP1 on mitochondrial membrane potential
- evaluate effect of AP1 on Bcl-2 family proteins
- evaluate effect of AP1 on caspase activities

